Poster – The Complexity Of Myeloid-derived Suppressor Cells In Non-Small Cell Lung Cancer: A Combinatorial Multiplex IHC And Flow Cytometry Approach
Lung cancer is the leading cause of cancer deaths worldwide. Non-small cell…
Read more
Case Study – Pediatrics Study In Mucopolysaccharidosis Type III (MPSIIIA)
Discover how our scientists performed an open, non-controlled, parallel, ascending multiple-dose, multicentre…
Read more
Flyer – SARS-Cov-2 ELISpot: A New Test In The Covid-19 Diagnostic And Vaccine Arsenal
Following SARS-CoV-2 infection, an innate immune response occurs rapidly at the infection…
Read more
Case Study – Tech Transfer China For IFE Reflex Assay
Biotech Company in China required our scientific expertise for the Tech Transfer…
Read more
Flyer – Turning Precision Medicine Into Action
CerbACT Asia empowers precision medicine development and drives better patient outcomes by…
Read more
Publication – Measurable Success: The Value Of Biomarkers From Discovery Through Commercialization
Why do some patients respond to therapy while others do not? The…
Read more
Poster – Solid Tumor Analytical Validation Of A T-Regulatory Immunohistochemistry Multiplex For Clinical Studies
Accurate characterization of the tumor micro-environment when tissue sample access is limited…
Read more
Publication – Change The Shape Of Your Clinical Development
At Cerba Research we are built on more than 50 years of…
Read more
Article – The New Big Data Application That Is Reshaping Clinical Trials
The new big data application is reshaping clinical trials. Someone on the…
Read more
Case Study – Phase 3 CAR-T vs SOC In Relapse Refractory Multiple Myeloma (RRMM)
Discover how effective we are in immunophenotyping for a Car-T therapy take…
Read more
Case Study – Phase 1 Dose Escalation Study With A Bispecific Antibody In Relapse Refractory Multiple Myeloma (RRMM)
Discover how we manage routine and specialty test for a Phase 1…
Read more
Case Study – Phase 2 To Determine Safety And Efficacy Of A mAB CKI Combo In Relapse Refractory Multiple Myeloma (RRMM)
Discover how we managed cell isolation and counts among other routine and…
Read more
Article – The Value Of Biomarkers From Discovery To Commercialization
Why do some patients respond to therapy while others do not? The…
Read more
Article – Cerba Research Expands U.S. Immuno-Oncology Center Of Excellence To Strengthen Its Precision Medicine Offerings
Cerba Research established its United States presence as a leading clinical diagnostics…
Read more
Case Study – How Cerba Research Helped Advance A Phase 1B Study In The Middle Of A Pandemic And Brexit
A two-country clinical trial that involves a nasopharyngeal swab and two assays…
Read more
Case Study – Tech Transfer IFE Reflex Assay China
A Biotech Company in China required our scientific expertise for the Tech…
Read more
Case Study – Pediatric Phase I/II/III Study In X-Linked Myotubular Myopathy (XLMTM)
Lab support for a global pediatric trial for the rare neuromuscular disease,…
Read more
Case Study – Pediatric Phase I/II Clinical Trial on Mucopolysaccharidosis type III (MPSIIIA)
Lab support for a global pediatric trial for the rare genetic neurodegenerative…
Read more
Case Study – Lab Support For The Largest Global Phase III NASH Study To Date
In a meta-analysis of several studies using various methodologies, worldwide prevalence of…
Read more
Together, we can shape the future of your clinical development. Find out more about how we can support your research.